Study: Single Dose of Modified Smallpox Vaccine Effective for Mpox
A single dose of the modified vaccinia Ankara–Bavarian Nordic (MVA-BN) smallpox vaccine is 58% effective against mpox infection, according to a study in The BMJ. The results were based on 9800 men aged 18 years or older in Canada and come as mpox cases continue to spread in regions of Africa.
Authors
- Samantha Anderer
Publication Details
- Journal
- JAMA
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1001/jama.2024.20120
- Primary Topic
- Poxvirus research and outbreaks
- Type
- article
- Field-Weighted Citation Impact
- 0.00